High-dose hepatitis B immunoglobulin therapy in hbv-DNA/HBeAg-positive hcc patients after living donor liver transplantation. (April 2016) - Lee, E.-C.; Kim, S.H.; Lee, S.D.; Lee, S.-A.; Park, S.-J.